Drug & intervention
ado-trastuzumab emtansine 160 MG Injection [KADCYLA]
RxCUI 1658091
What this record represents
SBD · RxNormThis is an RxNorm SBD drug concept. Its name, formulation details and source identifiers are preserved to distinguish it from other drug records.
What this record does not establish: current marketing availability, therapeutic equivalence, safety, or official approval status. Check an up-to-date product label or a pharmacist for product-specific questions.
Related drug records
RxNorm name matchesThese are other published drug concepts with matching brand or formulation names. They are not necessarily equivalent medicines.
KADCYLABN · CureCurrent ID 55658
trastuzumab Injection [KADCYLA]SBDF · CureCurrent ID 60171
ado-trastuzumab emtansine 100 MG [KADCYLA]SBDC · CureCurrent ID 60170
ado-trastuzumab emtansine 160 MG [KADCYLA]SBDC · CureCurrent ID 60175
ado-trastuzumab emtansine 100 MG Injection [KADCYLA]SBD · CureCurrent ID 60172
Advertisement
Clinical trials
1 shownConditions being studied
Advertisement
Leading sponsors
Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.